2025 Annual Report of Independent Director (Beisai)
I, Beisai, as the independent director of Nabai Chuan New Energy Co., Ltd. (hereinafter referred to as "the Company"), have strictly adhered to the Company Law, the Management Measures for Independent Directors of Listed Companies, the Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 2 - Normative Operations of GEM Listed Companies, and other relevant laws and regulations, as well as the Company’s Articles of Association. I have fulfilled my duties with loyalty, integrity, diligence, and responsibility, effectively playing the role of an independent director to safeguard the overall interests of the Company and the legitimate rights and interests of all shareholders. The following is a report on my work in 2025:
I. Basic Information of the Independent Director
Mr. Beisai, born in January 1984, is a Chinese national without permanent residency abroad, holds a master's degree, and is a first-class lawyer. He has served as an independent director of Zhejiang Shouxian Valley Pharmaceutical Co., Ltd. and has been with Zhejiang Zhihang Law Firm since October 2010, currently serving as managing partner. He has been an independent director of Zhejiang Chaohui Filtration Technology Co., Ltd. since August 2020, an independent director of Zhejiang Jiansheng Group Co., Ltd. since May 2023, and an independent director of the Company since January 2023. As an independent director, I do not hold any position in the Company other than that of independent director, nor do I hold any position in the Company’s major shareholders. There are no relationships that hinder my independent and objective judgment, and I meet the independence requirements set forth in the Management Measures for Independent Directors of Listed Companies, the Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 2, and the Company’s Articles of Association.
II. Performance Overview in 2025
(1) Attendance at Board and Shareholder Meetings
During my tenure in 2025, the Company held 6 board meetings and 4 shareholder meetings. I diligently attended all board meetings, shareholder meetings, and special committees as required by relevant laws and regulations. The convening of board and shareholder meetings in 2025 complied with legal procedures, and I voted in favor of all proposals and matters without raising objections, dissent, or abstentions. My attendance at meetings is as follows:
| Meeting Type | Required Attendance | Actual Attendance | Proxy Attendance | Absences | Consecutive Absences |
|---|---|---|---|---|---|
| Board Meeting | 6 | 6 | 0 | 0 | No |
| Shareholder Meeting | 4 | 4 | 0 | 0 |
(2) Attendance at Special Meetings of Independent Directors
In 2025, the Company held 1 special meeting for independent directors. I strictly followed the Company Law, Securities Law, Management Measures for Independent Directors of Listed Companies, and the Company’s Articles of Association to review matters such as the profit distribution plan for 2024, confirmation of related party transactions for 2024, expected daily related party transactions for 2025, and the appointment of the auditing firm for 2025. I believe that the review procedures for these matters were legal and compliant, and the content met relevant laws and regulations, effectively fulfilling the supervisory responsibilities of independent directors and safeguarding the legitimate rights and interests of the Company and all shareholders.